NSE · Healthcare · Drug Manufacturers - Specialty & Generic
| Document | Date |
|---|---|
| Annual report FY2026 BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED – ANNUAL REPORT 2025-26 SUMMARY --- HEADLINE NUMBERS • Total Revenue: ₹2,839.52 lakhs (FY 2025-26) vs | 2026-08-26 |
| Quarterly results · Q1 FY27 BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED – SUMMARY HEADLINE NUMBERS • Q1 FY2027 (Quarter ended June 30, 2026) Revenue from Operations: 1,235.02 | 2026-08-11 |
| Quarterly results · Q4 FY26 BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Full Year FY2026 (Year ended 31 March 2026): - Revenue from Op | 2026-05-30 |
| Quarterly results · Q3 FY26 BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED Summary for Retail Investors --- HEADLINE NUMBERS • Q3 FY2025-26 Revenue from Operations: 85.63 lakhs | 2026-02-13 |
| Quarterly results · Q2 FY26 BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Q2 FY2025-26 (ended 30 Sept 2025): Net profit of Rs 8.36 lakhs • | 2025-11-13 |
| Annual report FY2025 BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED — ANNUAL REPORT 2024-25 SUMMARY --- HEADLINE NUMBERS • Total Revenue from Operations: ₹3,340.22 lakhs | 2025-08-29 |
| Quarterly results · Q1 FY26 BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED - SUMMARY HEADLINE NUMBERS • Q1 FY2025-26 (Quarter ended 30 June 2025): - Revenue from Operations: ₹6 | 2025-08-12 |
| Quarterly results | 2025-02-11 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Biofil Chemicals & Pharmaceuticals Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.